RichardMichaelNovakMD
Infectious Disease • Chicago, ILProfessor of Medicine, University of Illinois College of Medicine
Dr. Novak is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
845 W Wilson Ave
Chicago, IL 60640Phone+1 312-744-1295
Education & Training
University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 1981 - 1984
Rush Medical College of Rush University Medical CenterClass of 1981
Certifications & Licensure
IL State Medical License 1982 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2014
- Chicago Magazine: Top Doctors Castle Connolly, 2014
Clinical Trials
- A Study to Evaluate the Long-Term Effectiveness of Three Anti-HIV Drug Regimens in HIV Infected Patients Who Have Never Been Exposed to Highly Active Antiretroviral Therapy (HAART)
- Respiratory Virus Hospitalization Study (FLU 003 Plus)
Roles: Principal Investigator, Contact
- Respiratory Virus Outpatient Study (FLU 002 Plus) Start of enrollment: 2009 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citations2024 Update of the RECOVER-Adult Long COVID Research Index.Linda N Geng, Kristine M Erlandson, Mady Hornig, Rebecca Letts, Caitlin Selvaggi
JAMA. 2025-02-25 - 1 citationsNeutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial.Youyi Fong, Lauren Dang, Bo Zhang, Jonathan Fintzi, Shiyu Chen
Clinical Infectious Diseases. 2025-02-05 - Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost.Bo Zhang, Youyi Fong, Lauren Dang, Jonathan Fintzi, Shiyu Chen
Nature Communications. 2025-01-17
Journal Articles
- Effects of Different Doses of GEN-003, a Therapeutic Vaccine for Genital HSV-2, on Viral Shedding and Lesions: Results of a Randomized Placebo-Controlled TrialDavid I Bernstein, John Kriesel, William Koltun, Gregg Lucksinger, Peter A Leone, Richard Beigi, Stephen Tyring, Richard M Novak, Seth Hetherington, The Journal of Infectious Diseases
Press Mentions
A $22 Million Post-COVID Research Project Now Recruiting in ChicagoMarch 31st, 2022- Illinois COVID Update: IL Reports 15,453 New Cases, 120 DeathsJanuary 28th, 2022
- Illinois COVID Update: IL Reports 14,422 New Cases, 149 DeathsJanuary 27th, 2022
- Join now to see all
Grant Support
- Targeting High-Risk Women For HVTN And Microbicide TrialsNational Institute Of Allergy And Infectious Diseases2007–2012
- HIV Specific Immunity In Highly Exposed Uninfected WomenNational Institute Of Allergy And Infectious Diseases2009–2011
- Diversity Supplement For HIV Susceptibility &Pathogenesis In The Female GenitalNational Institute Of Allergy And Infectious Diseases2010
- Female Genital Tract Immunity And HIV Vaccine ResponsesEunice Kennedy Shriver National Institute Of Child Health &Human Development2001–2002
- HIV Treatment Error Reduction Using A Genotype DatabaseAgency For Healthcare Research And Quality2001–2002
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
